down arrow

Crinetics Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US22663K1079
USD
47.42
2.41 (5.35%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Harmony Biosciences Holdings, Inc.
IDEAYA Biosciences, Inc.
Vericel Corp.
PTC Therapeutics, Inc.
Xenon Pharmaceuticals, Inc.
Ultragenyx Pharmaceutical, Inc.
Crinetics Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc.
Akero Therapeutics, Inc.
Biohaven Ltd.
Neumora Therapeutics, Inc.
Why is Crinetics Pharmaceuticals, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -234.52% of over the last 5 years
2
The company has declared negative results for the last 25 consecutive quarters
  • OPERATING CASH FLOW(Y) Lowest at USD -301.79 MM
  • OPERATING PROFIT(Q) Lowest at USD -128.15 MM
  • PRE-TAX PROFIT(Q) Lowest at USD -115.64 MM
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -20.29%, its profits have fallen by -39.4%
4
Underperformed the market in the last 1 year
  • Even though the market (S&P 500) has generated returns of 12.33% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -20.29% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Crinetics Pharmaceuticals, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Crinetics Pharmaceuticals, Inc.
-16.2%
-0.01
60.87%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
19.04%
EBIT Growth (5y)
-234.52%
EBIT to Interest (avg)
-198.84
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.47
EV to EBIT
-4.84
EV to EBITDA
-4.88
EV to Capital Employed
-132.79
EV to Sales
1824.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-26.18%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company
NET PROFIT(HY)

Higher at USD -212.41 MM

RAW MATERIAL COST(Y)

Fallen by -698% (YoY

NET SALES(9M)

Higher at USD 1.39 MM

CASH AND EQV(HY)

Highest at USD 2,471.48 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 0.55 times

-24What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD -301.79 MM

OPERATING PROFIT(Q)

Lowest at USD -128.15 MM

PRE-TAX PROFIT(Q)

Lowest at USD -115.64 MM

NET PROFIT(Q)

Lowest at USD -115.64 MM

EPS(Q)

Lowest at USD -1.23

Here's what is working for Crinetics Pharmaceuticals, Inc.
Net Sales
At USD 1.39 MM has Grown at inf%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (USD MM)

Cash and Eqv
Highest at USD 2,471.48 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio
Highest at 0.55 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales
Higher at USD 1.39 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

Net Sales (USD MM)

Raw Material Cost
Fallen by -698% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Crinetics Pharmaceuticals, Inc.
Pre-Tax Profit
At USD -115.64 MM has Fallen at -56.15%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -115.64 MM has Fallen at -56.15%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow
Lowest at USD -301.79 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Operating Profit
Lowest at USD -128.15 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -115.64 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -115.64 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

EPS
Lowest at USD -1.23
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."